Hongbo Lu - Sep 7, 2022 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Hongbo Lu
Stock symbol
TERN
Transactions as of
Sep 7, 2022
Transactions value $
$2,160,000
Form type
4
Date filed
9/8/2022, 08:00 PM
Previous filing
Aug 16, 2022
Next filing
Dec 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $2.16M +600K +20.12% $3.60 3.58M Sep 7, 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein.